AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Velaf 37.5mg Tablet ER

Prescription Icon
Prescription Required

Marketer

Crescent Therapeutics Ltd

Salt Composition

Venlafaxine (37.5mg)

Overview Velaf 37.5mg Tablet ER

Eloron 37.5mg Extended-Release Tablets treat depression and anxiety. The medication modifies brain chemistry, alleviating anxiety symptoms like agitation, edginess, poor concentration, tiredness, perspiration, rapid heartbeat, and racing thoughts. Take Eloron 37.5mg ER with food, at the same time daily for consistent blood levels. If a dose is missed, take it immediately upon recall. Complete the prescribed course, even with symptom improvement; abrupt cessation may worsen your condition. Common side effects include queasiness, vomiting, sleeplessness, reduced appetite, nervousness, bowel irregularity, excessive sweating, and sexual difficulties. Dizziness and drowsiness are possible; avoid driving or mentally demanding tasks until the medication's effects are known. Most side effects are transient and self-limiting. Persistent or bothersome side effects warrant medical attention. Before starting Eloron 37.5mg ER, disclose any kidney, heart, or liver issues, or a history of seizures. Report any unusual mood or behavioral shifts, worsening depression, or suicidal ideation to your physician.

Primary Ingredients of Velaf 37.5mg Tablet ER

No information provided. Please provide the text you wish me to rephrase.

Uses of Velaf 37.5mg Tablet ER

Mood disorders encompassing depressive and anxious symptoms

Major Benefits of Velaf 37.5mg Tablet ER:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Velaf 37.5mg Extended-Release Tablet should be administered with a meal.

Common Side effects of Velaf 37.5mg Tablet ER:

  • Nausea
  • Vomiting
  • Dizziness
  • Insomnia (difficulty in sleeping)
  • Decreased appetite
  • Anxiety
  • Constipation
  • Increased sweating
  • Sexual dysfunction

How to use Velaf 37.5mg Tablet ER:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Velaf 37.5mg Extended-Release Tablet should be taken with a meal.

How Velaf 37.5mg Tablet ER works:

Extended-release Velaf 37.5mg tablets function by elevating brain concentrations of serotonin and noradrenaline, neurotransmitters crucial for emotional equilibrium.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Velaf 37.5mg Extended-Release Tablets with alcohol is hazardous.

PregnancyPregnancyCONSULT YOUR DOCTOR

Extended-release Velaf 37.5mg tablets may pose pregnancy risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Extended-release Velaf 37.5mg tablets are likely unsafe for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a risk to the infant. Close observation of infants for drowsiness and appropriate weight increase is recommended.

DrivingDrivingUNSAFE

Driving ability may be impaired by Velaf 37.5mg Extended-Release Tablets due to potential side effects. These side effects include dizziness, confusion, and visual disturbances like blurred vision, all of which can impact safe driving.

KidneyKidneyCAUTION

Patients with kidney impairment should use Velaf 37.5mg Extended-Release tablets cautiously. Dosage modification for Velaf 37.5mg Extended-Release tablets may be necessary. Physician consultation is advised.

LiverLiverCAUTION

Patients with hepatic impairment should use Velaf 37.5mg Extended-Release Tablets cautiously. Dosage modification may be necessary; physician consultation is advised.

What if you forget to take Velaf 37.5mg Tablet ER :

Should you forget a Velaf 37.5mg Extended-Release Tablet, take it immediately. If your next dose is imminent, however, omit the missed dose and resume your usual dosing regimen. Never take a double dose.

Facts to Know About Velaf 37.5mg Tablet ER

LabelValue
Chemical Type Anisole-based compound
Developing Habits No.
Treatment Category Neuroscience of the Central Nervous System
Behavior Class SNRIs (serotonin-norepinephrine reuptake inhibitors)

FAQs on Velaf 37.5mg Tablet ER

Sedation is a possible side effect of Velaf 37.5mg Tablet ER. Inform your doctor about all other sleep aids you're using before starting this medication.
Yes. Velaf 37.5mg Tablet ER is a psychotropic medication; these medications affect mental state, emotions, and behavior.
Velaf 37.5mg Extended-Release Tablets are not narcotics. Narcotics are opioid-derived drugs, such as heroin and morphine, that cause drowsiness.
Velaf 37.5mg tablets, whether ER or XR, are the same extended-release medication. This formulation slowly releases the drug, maintaining consistent therapeutic levels. Extended-release reduces the frequency of dosing.
Mirtazapine and Velaf 37.5mg ER tablets together pose a serious risk of serotonin syndrome. This potentially life-threatening condition may manifest as agitation, hallucinations, nausea, vomiting, diarrhea, rapid heart rate, fluctuating blood pressure, high fever, and coma.
Combining citalopram and Velaf 37.5mg ER tablets, which both raise serotonin levels, risks serotonin syndrome. This potentially life-threatening condition may manifest as agitation, hallucinations, nausea, vomiting, diarrhea, rapid heart rate, fluctuating blood pressure, high fever, and coma. Avoid concurrent use; an alternative medication should be considered.
P-glycoprotein pumps Velaf 37.5mg Tablet ER out of the brain. However, some research indicates that Velaf 37.5mg Tablet ER and its metabolite can also inhibit p-glycoprotein.
The extended-release Velaf 37.5mg tablet is absorbed in the intestines following hepatic metabolism.
Velaf 37.5mg Extended-Release Tablets treat generalized depression. Always consult your physician before use.
Treatment with Velaf 37.5mg Tablet ER may cause a sustained rise in blood pressure in some patients. Regular blood pressure monitoring is recommended for those taking Velaf 37.5mg Tablet ER; dose adjustment or discontinuation may be necessary.
Constipation is a known side effect of Velaf 37.5mg Tablet ER. Increase fiber and water intake, and consider using laxatives. Your doctor can offer management strategies; consult them if the constipation persists or worsens.
Yes, Velaf 37.5mg Extended-Release tablets have been associated with weight loss in some patients. Studies show this weight loss increases with higher doses and longer treatment durations. Consult your physician if this is a concern.
Velaf 37.5mg Extended-Release Tablets are not habit-forming.
A doctor's guidance is necessary to switch from capsules to tablets, as formulations differ and affect drug release, potentially causing treatment failure or side effects. Self-substitution is inadvisable.
Gabapentin and Velaf 37.5mg ER tablets may be used together, but only under a doctor's supervision. Concurrent use may increase drowsiness, sleepiness, and impair concentration. Caution is advised.
Desvenlafaxine is the active ingredient in Velaf 37.5mg Extended-Release Tablets.
Velaf 37.5mg ER tablets are not currently FDA-approved for fibromyalgia, although some studies suggest potential benefits. Always consult your physician before using this medication for fibromyalgia or any other condition.
While not FDA-approved for nerve pain, Velaf 37.5mg Extended-Release tablets have shown efficacy in some research studies and are therefore sometimes used off-label for this purpose.
Velaf 37.5mg Extended-Release tablets alter brain neurotransmitter levels, resulting in dose-dependent appetite suppression.
Experience decreased sex drive or impotence? Consult your doctor, who may prescribe an alternative medication. Do not discontinue Velaf 37.5mg Tablet ER without medical supervision; doing so may worsen side effects.
Velaf 37.5mg Tablet ER
25
MRP 29
13% off